Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Rapamycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/24/2020 Oct/17/2020 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Sep/23/2020 Oct/19/2020 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/18/2020 Oct/10/2020 0
Nebivolol Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/16/2020 Oct/07/2020 0
Calpain inhibitor II Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/05/2020 Oct/01/2020 0
Calpain inhibitor XII Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/05/2020 Oct/01/2020 0
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Sep/05/2020 Oct/01/2020 0
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/04/2020 Sep/26/2020 0
Calcifediol Potential treatment - clinical evidence Used to treat other disease Antiviral Aug/29/2020 Oct/08/2020 0
S1-Fc vaccine Potential treatment - pre-clinical evidence Experimental Vaccine Jul/31/2020 Sep/02/2020 0